Prednisone Dosing Guidelines for Children

Introduction to Prednisone Dosing

The American Academy of Pediatrics recommends prednisone dosing for a 3-year-old child at 2 mg/kg/day or 60 mg/m²/day (maximum 60 mg/day) as a single morning dose, with the specific indication determining the duration and tapering schedule 1, 2

Weight-based dosing (2 mg/kg/day) is simpler and commonly used in clinical practice, while BSA-based dosing (60 mg/m²/day) is preferred by major guidelines because it parallels prednisone metabolism better and reduces the risk of underdosing in younger children 1, 2, 3, 4

For nephrotic syndrome (initial episode), the initial phase involves 60 mg/m²/day (maximum 60 mg) as a single morning dose for 4-6 weeks, followed by an alternate-day phase with 40 mg/m²/dose or 1.5 mg/kg/dose (maximum 40 mg) for 2-5 months 3, 4, 5, 6
For acute asthma exacerbation, dosing is 1-2 mg/kg/day (typically 15-30 mg/day for a 15 kg child) as a single daily dose for 3-10 days, with no tapering needed if duration is less than 10 days 2, 7
For autoimmune conditions, initial dose is 2 mg/kg/day or 60 mg/m²/day (maximum 60 mg) as a single daily dose, with adjustments based on disease severity 1, 2, 7

Prednisone should be given as a single morning dose before 9 AM to align with the body's natural cortisol rhythm and minimize HPA axis suppression 2
For courses longer than 2 weeks, gradual tapering is essential to prevent adrenal insufficiency, with an initial taper reducing by 25-33% at appropriate intervals once clinical response is achieved 2, 7

Always use ideal body weight, not actual body weight, for obese children to avoid overdosing and increased side effects, with a maximum dose of 60 mg daily considered even if calculated doses exceed this 1, 2, 5, 8

Essential monitoring during prednisone therapy includes growth parameters, blood pressure, signs of Cushingoid features, and consideration of calcium and vitamin D supplementation 1, 2, 7

Common side effects include weight gain, increased appetite, cosmetic changes, growth deceleration, and severe side effects are uncommon but more likely after prolonged therapy (>18 months) 1, 7
Consider steroid-sparing agents if frequent relapses occur, steroid-dependent pattern develops, or significant steroid-related adverse effects emerge 5, 6